year 22, Issue 87 (12-2023)                   J. Med. Plants 2023, 22(87): 89-96 | Back to browse issues page

Ethics code: IR.MUMS.REC.1396.142
Clinical trials code: IRCT20170821035817N1

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kianbakht S, Nabati F, Hashem Dabaghian F. Effects of topical Persian medicine Amygdalus communis L. var. Amara kernel oil on the symptoms of knee osteoarthritis: a randomized, triple-blind, active, and placebo-controlled clinical trial. J. Med. Plants 2023; 22 (87) :89-96
1- Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran ,
2- Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran
3- Department of Traditional Medicine, Institute for Studies in Medical History, Persian and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (819 Views)
Background: The Amygdalus communis L. var. Amara (bitter almond) kernel oil (ACKO) is used topically for palliation of musculoskeletal and joint pains in the Traditional Persian Medicine. Also, it had anti-inflammatory effects in experimental studies. Objective: Evaluation of the efficacy and safety of ACKO in the symptomatic treatment of knee osteoarthritis. Methods: One hundred and fifty six patients were equally randomized to apply ACKO, diclofenac, or placebo to their knees every 8 hours for 1 month. Fifty two, 50, and 51 patients in the ACKO, diclofenac, and placebo groups, respectively, finished the trial. At the trial’s start and end, the symptoms were assessed using the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) questionnaire. Also, hematological, and liver and kidney function tests were performed. Results: Both ACKO and diclofenac reduced the symptoms significantly more than the placebo (P ˂ 0.001). The percent changes of the WOMAC pain and stiffness scores in the ACKO group were similar to the diclofenac group while the percent changes of the WOMAC function and total scores in the ACKO group were less than the diclofenac group (P ˂ 0.001). ACKO and diclofenac had no significant effect on the blood tests. Moreover, no adverse effect was identified. Conclusions: Topical ACKO and diclofenac are safe, and superior to placebo in reducing the symptoms of OA. While ACKO is similar to diclofenac in alleviating pain and stiffness, ACKO is less effective than diclofenac in improving the WOMAC total and function scores.
Full-Text [PDF 356 kb]   (460 Downloads)    
Type of Study: Research | Subject: Pharmacology & Toxicology
Received: 2023/07/19 | Accepted: 2023/12/20 | Published: 2023/12/31

1. Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M., Zhong Y, He T, Chen S and Xiao G. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct. Target. Ther. 2023; 8(1): 56. [DOI:10.1038/s41392-023-01330-w]
2. Richard MJ, Driban JB and McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage. 2023; 31(4); 458-466. [DOI:10.1016/j.joca.2022.11.005]
3. Dragos D, Gilca M, Gaman L, Vlad A, Iosif L, Stoian I and Lupescu O. Phytomedicine in joint disorders. Nutrients. 2017; 9(1): 70. [DOI:10.3390/nu9010070]
4. Zargari, A. Medicinal Plants. Sixth ed., Tehran: Tehran University Publications; 1996: 232-242.
5. Ziaei A, Sahranavard S and Faizi M. Topical herbal remedies for treatment of joint pain according to Iranian traditional medicine. Res. J. Pharmacogn. 2016; 3(3): 63-72.
6. El Kouacheur KG, Cherif HS, Saidi F, Bensouici C and Fauconnier ML. Prunus amygdala var. Amara (bitter almond) seed oil: fatty acid composition, physicochemical parameters, enzyme inhibitory activity, antioxidant and anti-inflammatory potential. Journal Food Meas. Charact. 2023; 17: 371-384. [DOI:10.1007/s11694-022-01629-2]
7. Nadrian H, Moghimi N, Nadrian E, Moradzadeh R, Bahmanpour K, Iranpour A and Bellamy N. Validity and reliability of the Persian versions of WOMAC Osteoarthritis index and lequesne algofunctional index. Clin. Rheumatol. 2012; 31(7): 1097-1102. [DOI:10.1007/s10067-012-1983-7]
8. Angst F, Aeschlimann A, Michel B and Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J. Rheumatol. 2002; 29(1): 131-138.
9. Revel FB, Fayet M and Hagen M. Topical diclofenac, an efficacious treatment for osteoarthritis: a narrative review. Rheumatol. Ther. 2020; 7(2): 217-236. [DOI:10.1007/s40744-020-00196-6]
10. Knights AJ, Redding SJ and Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr. Opin. Rheumatol. 2023; 35(2): 128-134. [DOI:10.1097/BOR.0000000000000923]
11. Ringbom T, Huss U, Stenholm A, Flock S, Skattebol L, Perera P and Bohlin L. Cox-2 inhibitory effects of naturally occurring and modified fatty acids. J. Nat. Prod. 2001; 64(6): 745-749. [DOI:10.1021/np000620d]
12. Fu K, Robbins SR and McDougall JJ. Osteoarthritis: the genesis of pain. Rheumatol. (Oxford). 2018; 57(suppl_4): iv43-iv50. [DOI:10.1093/rheumatology/kex419]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Medicinal Plants

Designed & Developed by : Yektaweb